Oxford BioMedica plc (OXBDF)
OTHER OTC:OXBDF
Total Valuation
Oxford BioMedica has a market cap or net worth of $895.09M. The enterprise value is $686.64M.
Market Cap$895.09M
Enterprise Value$686.64M
Share Statistics
Oxford BioMedica has 120,900,850 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding120,900,850
Owned by Insiders0.39%
Owned by Institutions1.89%
Financial Efficiency
Oxford BioMedica’s return on equity (ROE) is -0.33 and return on invested capital (ROIC) is -13.00%.
Return on Equity (ROE)-0.33
Return on Assets (ROA)-0.09
Return on Invested Capital (ROIC)-13.00%
Return on Capital Employed (ROCE)-0.14
Revenue Per Employee198.52K
Profits Per Employee-35.44K
Employee Count850
Asset Turnover0.52
Inventory Turnover5.93
Valuation Ratios
The current PE Ratio of Oxford BioMedica is ―. Oxford BioMedica’s PEG ratio is 0.64.
PE Ratio―
PS Ratio4.09
PB Ratio7.56
Price to Fair Value7.56
Price to FCF-67.62
Price to Operating Cash Flow-108.72
PEG Ratio0.64
Income Statement
In the last 12 months, Oxford BioMedica had revenue of 168.74M and earned -30.13M in profits. Earnings per share was -0.27.
Revenue168.74M
Gross Profit65.98M
Operating Income-33.54M
Pretax Income-31.94M
Net Income-30.13M
EBITDA-33.54M
Earnings Per Share (EPS)-0.27
Cash Flow
In the last 12 months, operating cash flow was -5.45M and capital expenditures -4.76M, giving a free cash flow of -10.21M billion.
Operating Cash Flow-5.45M
Free Cash Flow-10.21M
Free Cash Flow per Share-0.08
Dividends & Yields
Oxford BioMedica pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.35
52-Week Price Change133.17%
50-Day Moving Average9.64
200-Day Moving Average8.03
Relative Strength Index (RSI)32.90
Average Volume (3m)3.47K
Important Dates
Oxford BioMedica upcoming earnings date is Sep 23, 2026, TBA (Confirmed).
Last Earnings DateMar 26, 2026
Next Earnings DateSep 23, 2026
Ex-Dividend Date―
Financial Position
Oxford BioMedica as a current ratio of 2.20, with Debt / Equity ratio of 116.74%
Current Ratio2.20
Quick Ratio2.00
Debt to Market Cap<0.01
Net Debt to EBITDA-0.29
Interest Coverage Ratio-1.92
Taxes
In the past 12 months, Oxford BioMedica has paid -1.29M in taxes.
Income Tax-1.29M
Effective Tax Rate0.04
Enterprise Valuation
Oxford BioMedica EV to EBITDA ratio is -20.88, with an EV/FCF ratio of -68.57.
EV to Sales4.15
EV to EBITDA-20.88
EV to Free Cash Flow-68.57
EV to Operating Cash Flow-128.45
Balance Sheet
Oxford BioMedica has $96.88M in cash and marketable securities with $106.64M in debt, giving a net cash position of -$9.76M billion.
Cash & Marketable Securities$96.88M
Total Debt$106.64M
Net Cash-$9.76M
Net Cash Per Share-$0.08
Tangible Book Value Per Share$0.59
Margins
Gross margin is 39.10%, with operating margin of -19.88%, and net profit margin of -17.85%.
Gross Margin39.10%
Operating Margin-19.88%
Pretax Margin-18.93%
Net Profit Margin-17.85%
EBITDA Margin-19.88%
EBIT Margin-19.88%
Analyst Forecast
The average price target for Oxford BioMedica is $12.18, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target$12.18
Price Target Upside54.14% Upside
Analyst ConsensusStrong Buy
Analyst Count4
Revenue Growth Forecast―
EPS Growth Forecast―